豪展

+0.90 (+2.52%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

36.5529成交張數6.56本益比1.24股價淨值比5.47%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	18	11	37.3%	1.58	27.20	22.6%	15.0%	0.4	0.2
2026Q1	15	10	32.3%	1.68	24.75	12.6%	8.9%	-0.1	-0.4
2025Q4	14	10	26.5%	1.90	23.96	10.2%	7.3%	0.4	-0.1
2025Q3	13	10	26.5%	2.00	23.43	9.4%	6.4%	-0.0	-1.1
2025Q2	13	9	28.6%	2.15	22.01	7.8%	5.3%	0.3	-0.1
2025Q1	14	10	26.3%	2.45	24.63	7.7%	5.4%	-0.0	-0.5
2024Q4	12	8	29.6%	2.05	22.79	6.7%	4.8%	1.3	1.1
2024Q3	14	9	36.4%	1.78	23.35	2.4%	1.6%	0.5	-0.1
2024Q2	14	9	36.3%	1.91	24.48	1.6%	1.1%	0.4	0.4
2024Q1	13	9	34.6%	1.94	23.98	1.4%	1.0%	-0.3	-0.3
2023Q4	12	9	28.3%	2.24	24.16	4.8%	3.3%	0.6	0.6
2023Q3	13	9	31.9%	2.03	24.79	8.4%	5.6%	0.4	0.3
2023Q2	13	9	33.5%	2.00	24.32	10.9%	7.1%	0.4	0.4
2023Q1	13	9	28.4%	2.26	25.22	10.7%	7.1%	0.7	0.7
2022Q4	13	9	31.9%	2.01	24.78	10.9%	6.7%	1.2	0.9
2022Q3	14	9	34.5%	1.90	25.46	11.6%	7.0%	1.1	1.0
2022Q2	14	9	35.8%	1.78	25.24	11.3%	6.3%	0.1	-0.0
2022Q1	16	10	37.3%	1.77	26.55	15.5%	8.0%	2.5	2.4
2021Q4	17	10	43.8%	1.56	25.78	33.9%	14.9%	0.4	0.3
2021Q3	17	9	44.8%	1.53	25.05	51.0%	25.4%	-0.1	-0.2
2021Q2	20	10	50.2%	1.47	27.04	76.4%	38.1%	2.0	1.8
2021Q1	25	11	55.1%	1.43	29.28	73.5%	37.6%	0.0	-0.3
2020Q4	25	9	64.1%	1.22	24.07	72.5%	29.1%	4.0	3.1
2020Q3	21	9	54.4%	1.43	24.97	52.2%	23.2%	-0.3	-0.7
2020Q2	14	7	50.2%	1.47	21.76	33.1%	14.9%	-0.6	-0.7
2020Q1	11	7	35.0%	2.02	21.56	23.4%	12.7%	1.0	1.0
2019Q4	10	5	49.5%	2.03	15.72	27.6%	12.3%	1.0	0.9
2019Q3	11	4	57.7%	1.75	13.46	34.9%	13.7%	0.2	0.1
2019Q2	10	4	61.5%	1.61	12.05	30.9%	11.8%	0.3	0.3
2019Q1	10	4	56.7%	1.82	13.12	25.0%	11.0%	0.7	0.6
2018Q4	11	4	60.8%	1.68	12.40	22.8%	9.6%	0.8	0.6
2018Q3	11	4	63.7%	1.62	11.93	16.9%	6.8%	-0.4	-0.4
2018Q2	10	4	62.3%	1.68	11.37	21.6%	8.8%	0.1	-0.0
2018Q1	10	5	54.9%	2.00	13.55	20.2%	10.1%	0.6	0.5
2017Q4	10	4	54.7%	1.27	13.05	23.1%	11.4%	0.2	-0.6
2017Q3	10	4	56.1%	1.42	13.01	26.4%	12.3%	0.6	0.4
2017Q2	9	4	56.2%	1.23	12.03	27.4%	12.8%	-0.1	-0.1
2017Q1	8	4	44.0%	1.84	13.17	20.3%	11.9%	0.8	0.7
2016Q4	8	4	45.6%	1.87	13.16	–	–	0.3	0.1
2016Q3	9	4	50.5%	1.71	12.65	–	–	-0.4	-0.4